| 2019 | | Comparisons of the Mucosal Healing Process between Flat and Protruded Type after Endoscopic Submucosal Dissection for Gastric Neoplasms | 김순선, 김진홍, 노충균, 신성재, 양민재, 유병무, 이광재, 이기명, 임선교, 정재연, 조성원, 조효정, 황재철 |
| 2018 | | Tamoxifen-Induced Non-alcoholic Steatohepatitis Cirrhosis | 김순선, 김영배, 정재연, 조성원 |
| 2018 | | FRI-151: Treatment and prognosis of hepatic epithelioid hemangioendothelioma based on SEER data analysis from 1973 to 2007 | 김순선, 노오규, 정재연, 조성원, 조효정 |
| 2018 | | EpCAM as a Predictive Marker of Tumor Recurrence and Survival in Patients Who Underwent Surgical Resection for Hepatocellular Carcinoma | 김봉완, 김순선, 김영배, 노진, 노충균, 양민재, 왕희정, 윤소영, 이길호, 정재연, 조성원, 조효정, 황재철 |
| 2018 | | Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects | 김순선, 김진홍, 양민재, 임선교, 정재연, 조성원, 조효정 |
| 2018 | | Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis B | 김순선, 박래웅, 양민재, 정재연, 조성원, 조효정 |
| 2018 | | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | 김보현, 김순선, 김재근, 김진우, 김현지, 원제환, 이제희, 정재연, 조성원, 조효정 |
| 2017 | | Response to Dr Giannini et al | 김순선, 정재연, 조성원, 조효정 |
| 2017 | | Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib | 김보현, 김순선, 김재근, 신성재, 양민재, 유병무, 이광재, 이기명, 이제희, 임선교, 정재연, 조성원, 조효정, 황재철 |
| 2017 | | Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population | 조성원 |
| 2017 | | Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma | 김순선, 김진우, 노충균, 신성재, 양민재, 원제환, 이기명, 정재연, 조성원, 조효정, 지재훈 |
| 2017 | | Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver | 강대용, 김보현, 김순선, 김재근, 신성재, 유병무, 이광재, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2017 | | Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment | 강대용, 김보현, 김봉완, 김순선, 김재근, 신성재, 양민재, 왕희정, 이기명, 이제희, 정재연, 조성원, 조효정, 황재철 |
| 2016 | | Evaluation of the Effectiveness of NK Vue Gold Kit in Patients with Chronic Hepatitis B | 김순선, 임영애, 정재연, 조성원 |
| 2016 | | Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis | 조성원 |
| 2016 | | Identification of NUCKS1 as a putative oncogene and immunodiagnostic marker of hepatocellular carcinoma | 김봉완, 김순선, 김영배, 왕희정, 정재연, 조성원 |
| 2016 | | Genetic polymorphisms in the Wnt/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 노충균, 신성재, 유병무, 이광재, 이기명, 정재연, 조성원, 조효정 |
| 2016 | | Endoscopic naso-gallbladder drainage versus gallbladder stenting before cholecystectomy in patients with acute cholecystitis and a high suspicion of choledocholithiasis: a prospective randomised preliminary study | 김순선, 김욱환, 김지훈, 김진홍, 신성재, 양민재, 유병무, 이광재, 이기명, 임선교, 정재연, 조성원, 황재철 |
| 2016 | | Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up | 김봉완, 김순선, 김영배, 김재근, 양민재, 왕희정, 유병무, 이광재, 이제희, 정재연, 조성원, 조혜성, 조효정 |
| 2016 | | Clinical course of partial virological responders under prolonged entecavir monotherapy in patients with chronic hepatitis B | 김순선, 박주한, 정재연, 조성원, 조효정 |
